Kijtawornrat Anusak, Ueyama Yukie, del Rio Carlos, Sawangkoon Suwanakiet, Buranakarl Chollada, Chaiyabutr Narongsak, Hamlin Robert L
* Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand;
Toxicol Sci. 2014 Feb;137(2):458-68. doi: 10.1093/toxsci/kft244. Epub 2013 Nov 4.
The evaluation of proarrhythmic and hemodynamic liabilities for new compounds remains a major concern of preclinical safety assessment paradigms. Contrastingly, albeit functional liabilities can also translate to clinical morbidity and mortality, lesser preclinical efforts are focused on the evaluation of drug-induced changes in inotrope and lusitrope, particularly in the setting of concomitant hemodynamic/arrhythmic liabilities. This study aimed to establish the feasibility of an anesthetized guinea pig preparation to assess functional liabilities in the setting of simultaneous drug-induced electrocardiographic/hemodynamic changes, by evaluating the effects of various compounds with known cardiovascular properties on direct and indirect indices of left ventricular function. In short, twenty nine male guinea pigs were instrumented to measure electrocardiograms, systemic arterial pressure, and left ventricular pressure-volume relationships. After baseline measurement, all animals were given intravenous infusions of vehicle and two escalating concentrations of either chromanol 293B (n = 8), milrinone (n = 6), metoprolol (n = 7), or nicorandil (n = 8) for 10 minutes each. In all cases, these compounds produced the expected changes. The slope of preload-recruitable stroke work (PRSW), a pressure-volume derived load independent index, was the most sensitive marker of drug-induced changes in inotropy. Among the indirect functional indices studied, only the "contractility index" (dP/dtmax normalized by the pressure at its occurrence) and the static myocardial compliance (ratio of end diastolic volume and pressure) appeared to be adequate predictors of drug-induced changes in inotropy/lusitropy. Overall, the data confirms that both electrophysiological and mechanical liabilities can be accurately assessed in an anesthetized guinea pig preparation.
对新化合物的促心律失常和血流动力学风险评估仍然是临床前安全性评估范式的主要关注点。相比之下,尽管功能风险也可能转化为临床发病率和死亡率,但临床前较少关注药物诱导的心肌收缩力和舒张功能变化的评估,特别是在伴有血流动力学/心律失常风险的情况下。本研究旨在通过评估具有已知心血管特性的各种化合物对左心室功能的直接和间接指标的影响,确定麻醉豚鼠制备模型在同时评估药物诱导的心电图/血流动力学变化时评估功能风险的可行性。简而言之,对29只雄性豚鼠进行仪器植入以测量心电图、体动脉压和左心室压力-容积关系。在基线测量后,所有动物分别静脉输注溶媒以及两种递增浓度的色满醇293B(n = 8)、米力农(n = 6)、美托洛尔(n = 7)或尼可地尔(n = 8),每种药物输注10分钟。在所有情况下,这些化合物均产生了预期的变化。前负荷可募集搏功(PRSW)斜率是一种由压力-容积推导得出的与负荷无关的指标,是药物诱导的心肌收缩力变化最敏感的标志物。在所研究的间接功能指标中,只有“收缩性指数”(dP/dtmax除以其发生时的压力)和静态心肌顺应性(舒张末期容积与压力之比)似乎是药物诱导的心肌收缩力/舒张功能变化的充分预测指标。总体而言,数据证实,在麻醉豚鼠制备模型中可以准确评估电生理和机械风险。